Pfizer Covid-19 vaccine faces last hurdle before US decision

A pharmacist labels syringes in a clean room where doses of Covid-19 vaccines will be handled at Mount Sinai Queens hospital in New York Picture: Mark Lennihan/AP

Pfizer’s Covid-19 vaccine faces one final hurdle as it races to become the first jab to be cleared for use in the US.

Thursday’s meeting of the Food and Drug Administration’s (FDA) vaccine advisory panel is likely the last step before a US decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus.